RiverFront Investment Group LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,711 shares of the healthcare conglomerate's stock after buying an additional 2,208 shares during the period. RiverFront Investment Group LLC's holdings in UnitedHealth Group were worth $15,030,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. Howard Capital Management Group LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. lifted its holdings in UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after buying an additional 180,479 shares in the last quarter. Kingfisher Capital LLC grew its stake in shares of UnitedHealth Group by 1.2% during the third quarter. Kingfisher Capital LLC now owns 2,923 shares of the healthcare conglomerate's stock valued at $1,709,000 after acquiring an additional 36 shares in the last quarter. Captrust Financial Advisors lifted its stake in shares of UnitedHealth Group by 0.9% in the third quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate's stock worth $123,054,000 after acquiring an additional 1,789 shares in the last quarter. Finally, Fred Alger Management LLC grew its stake in UnitedHealth Group by 91.9% during the 3rd quarter. Fred Alger Management LLC now owns 199,460 shares of the healthcare conglomerate's stock valued at $116,620,000 after purchasing an additional 95,503 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company's stock.
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded up $10.98 during midday trading on Monday, reaching $527.02. 2,887,666 shares of the company traded hands, compared to its average volume of 4,758,233. The stock has a 50-day moving average price of $508.81 and a 200 day moving average price of $543.92. The company has a market cap of $482.07 billion, a price-to-earnings ratio of 34.00, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm posted $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Barclays cut their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Buy" and an average price target of $629.32.
View Our Latest Research Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.